title: Adhesion mechanisms in liver metastasis formation.
abstract: Our results strongly indicate that integrin mediated adhesion between metastasizing tumour cells and hepatocytes has a decisive role in the formation of liver metastases. However, it is also clear that tumour cells may use different adhesion pathways and furthermore that the adhesion may be modulated by several factors. The role of adhesion has been demonstrated most clearly for LFA1 on T cell hybridomas, which interacts with ICAM1 present in the liver. Alternative pathways must exist, however, given the high invasive capacity of ESb cells, which is apparently LFA1 independent. A possible alternative is adhesion to fibronectin, which is present in abundance on the hepatocyte surface, both in vivo and in vitro. As there is no basement membrane under the endothelium of liver microvessels, so that tumour cells cannot adhere to laminin and collagen type IV as in other organs, adhesion to this fibronectin may be particularly important for metastasis to the liver. Many tumour types can use this pathway, and many different fibronectin receptors may be involved, including VLA-4, VLA-5 and several alpha V integrins. For carcinomas there is another possibility: Fibronectin receptor deficient cells may still adhere using the integrin alpha 6 beta 4, which binds to an unknown ligand present on the hepatocyte surface. Modulation of adhesion can occur in several ways. One example is steric hindrance by mucins that may strongly affect and even abrogate adhesion, despite high levels of appropriate integrins. Another is the activation required for integrins on lymphoma cells, the best known example of which is the activation of LFA1 on T cell hybridomas. It will be evident, therefore, that the role of adhesion in the formation of liver metastases can only be fully understood if the complete set of adhesion molecules on the tumour cells is known as well as their functional status and the possible effects of both cellular and extracellular modulating factors.
authors.affiliation: Division of Cell Biology, Netherlands Cancer Institute, Amsterdam.
authors.forename: H
authors.initials: H
authors.lastname: Kemperman
authors.forename: M H
authors.initials: MH
authors.lastname: Driessens
authors.forename: G
authors.initials: G
authors.lastname: La Rivière
authors.forename: A M
authors.initials: AM
authors.lastname: Meijne
authors.forename: E
authors.initials: E
authors.lastname: Roos
mesh_terms: D000954:Antigens, Surface / Q000502:physiology; D002448:Cell Adhesion; D005353:Fibronectins / Q000502:physiology; D019204:GTP-Binding Proteins / Q000502:physiology; D006801:Humans; D006825:Hybridomas / Q000473:pathology; D039161:Integrin alpha6beta4; D016023:Integrins / Q000502:physiology; D008113:Liver Neoplasms / Q000556:secondary*; D016169:Lymphocyte Function-Associated Antigen-1 / Q000502:physiology; D008223:Lymphoma / Q000473:pathology; D009077:Mucins / Q000494:pharmacology
chemical_list: D000954:Antigens, Surface; D005353:Fibronectins; D039161:Integrin alpha6beta4; D016023:Integrins; D016169:Lymphocyte Function-Associated Antigen-1; D009077:Mucins; D019204:GTP-Binding Proteins